Net Cash Provided by (Used in) Operating Activities |
-783 K |
USD |
-32.8% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
215 K |
USD |
-84.6% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
112 M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Common Stock, Shares Authorized |
50 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
3.22 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
84.5 K |
USD |
-78.4% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
122 K |
USD |
+85.5% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
122 K |
USD |
+85.5% |
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-56.1 K |
USD |
+14.5% |
Dec 31, 2023 |
Q4 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
451 K |
USD |
+45.5% |
Dec 31, 2023 |
Q4 2023 |